<DOC>
	<DOCNO>NCT03008057</DOCNO>
	<brief_summary>The aim study determine effect vitamin D placebo 3 month gene expression glyoxalase enzyme , RAGE , YKL40 peripheral blood mononuclear cell ( PBMC ) serum level YKL40 , AGEs , TNF-α , PAI-1 , IL-6 , HbA1c diabetes type 2 patient .</brief_summary>
	<brief_title>The Assessment Effect Vitamin D Supplementation Inflammatory Endothelial Factors Patients With Type 2 Diabetes .</brief_title>
	<detailed_description>The aim study determine effect vitamin D placebo 3 month gene expression plasma human cartilage glycoprotein 39 ( YKL40 ) , receptor advance glycation end product ( RAGE ) glyoxalase enzyme peripheral blood mononuclear cell ( PBMC ) serum level YKL40 , plasminogen activator inhibitor-1 ( PAI-1 ) , TNF-α , advance glycation end product ( AGEs ) , IL-6 , HbA1c diabetes type 2 patient . In randomized , double-blind clinical trial , placebo-controlled study , 84 woman men type 2 diabetes enrol Iranian Center diabetes . At start study , participant sign inform consent complete general information form . 24-hour food record 3 day take patient begin end study . Selected sample use stratified randomization method base sex , gender body mass index ( BMI ) classify 2 group : 1 ) receive vitamin D supplement 2 ) receive vitamin D placebo bo . The vitamin D supplement group receive 4000 IU ( 100 microgram ) daily 3 month . The vitamin D placebo group also receive placebo contain starch similar term color , shape size . participant advise maintain diet , level physical activity medication dose study . Blood sample collect anthropometric parameter measure target biochemical parameter , gene expression serum level physical activity measure trial .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>diabetic type 2 patient 3565 year old , body mass index range 18.5 30 , literate , willingness participation , avoidance dietary supplement , vitamin herbal product least 3 month throughout intervention people use vitamin D supplement last 3 month , chronic renal disease , GI disease , Hepatobilliary diseases , hematological disorder , hypo hyperthyroidism , treatment orlistat sibutramine weight loss , pregnancy lactation , treatment insulin Thiazolidinediones , Smokers , sever change regular diet life style , change type dosage regular medication ( )</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>YKL40</keyword>
	<keyword>PAI-1</keyword>
	<keyword>RAGE</keyword>
	<keyword>AGEs</keyword>
	<keyword>glyoxalase enzyme</keyword>
	<keyword>TNF-alpha</keyword>
	<keyword>IL-6</keyword>
	<keyword>Diabetes</keyword>
</DOC>